Kinase Inhibitors Beat Aggressive Skin T-Cell Lymphomas—Until Tumors Learn to Fight Back
A new review maps how aggressive cutaneous T-cell lymphomas develop resistance to targeted kinase inhibitors, revealing gatekeeper mutations and cross-kinase ...
